Skip to main content

Find Clinical Trials

Home
Conditions
Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma

Clinical trial condition

Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma

Explore clinical trials studying Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma trial results

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT01535924

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +16 more
Locations: Emory University Atlanta, Georgia, United States

Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

NCT00381940

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +30 more
Locations: Children's Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma

NCT01460940

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +12 more
Locations: Washington University St Louis, Missouri, United States

The Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Vorinostat in Treating Patients With Relapsed or Refractory Advanced Hodgkin's Lymphoma

NCT00132028

Conditions: Adult Favorable Prognosis Hodgkin Lymphoma, Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, +14 more
Locations: Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States

View Trial Details